• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

坏死性游走性红斑:病例报告及临床综述

Necrolytic migratory erythema: case report and clinical review.

作者信息

Adam David N, Cohen Paul D, Ghazarian Danny

机构信息

Department of Medicine, University of Toronto, Ontario, Canada.

出版信息

J Cutan Med Surg. 2003 Jul-Aug;7(4):333-8. doi: 10.1007/s10227-002-0127-0.

DOI:10.1007/s10227-002-0127-0
PMID:14738101
Abstract

BACKGROUND

Necrolytic Migratory Erythema (NME) is a rarely encountered dermatologic condition. It is the characteristic feature of a paraneoplastic syndrome associated with neuroendocrine pancreatic tumors. A case of NME initially diagnosed and treated as psoriasis is reviewed. A review of the current literature regarding NME is also included.

OBJECTIVE

The purpose of this report is to familiarize dermatologists with a rare and potentially fatal disorder. Early recognition of NME can lead to possible cure, while delayed identification of the disease is associated with metastatic disease and a poor prognosis for the patient.

CONCLUSION

When evaluating the patient who presents with a dermatitis and weight loss, it is important to exercise great caution. The differential diagnosis should be re-evaluated in a disease that is not responsive to first-line therapy before further treatment is considered.

摘要

背景

坏死性游走性红斑(NME)是一种罕见的皮肤病。它是与神经内分泌胰腺肿瘤相关的副肿瘤综合征的特征性表现。本文回顾了一例最初被诊断为银屑病并接受治疗的NME病例。同时也对当前关于NME的文献进行了综述。

目的

本报告的目的是让皮肤科医生熟悉一种罕见且可能致命的疾病。早期识别NME可能会带来治愈的可能,而疾病的延迟识别则与转移性疾病以及患者的不良预后相关。

结论

在评估出现皮炎和体重减轻的患者时,务必格外谨慎。在考虑进一步治疗之前,对于一线治疗无反应的疾病,应重新评估鉴别诊断。

相似文献

1
Necrolytic migratory erythema: case report and clinical review.坏死性游走性红斑:病例报告及临床综述
J Cutan Med Surg. 2003 Jul-Aug;7(4):333-8. doi: 10.1007/s10227-002-0127-0.
2
Successful treatment of a patient with octreotide-resistant necrolytic migratory erythema.用奥曲肽抵抗性游走性坏死性红斑成功治疗一名患者。
Br J Dermatol. 1996 Jun;134(6):1101-4.
3
Necrolytic Migratory Erythema: A Forgotten Paraneoplastic Condition.坏死松解性游走性红斑:一种被遗忘的副肿瘤性疾病。
J Cutan Med Surg. 2017 Nov/Dec;21(6):559-561. doi: 10.1177/1203475417719051. Epub 2017 Jun 29.
4
[The question of surgical therapy for necrolytic migratory erythema, a cutaneous disease].[坏死性游走性红斑(一种皮肤疾病)的外科治疗问题]
Chirurg. 2006 Jun;77(6):535-8. doi: 10.1007/s00104-005-1122-y.
5
Successful treatment of canine necrolytic migratory erythema (superficial necrolytic dermatitis) due to metastatic glucagonoma with octreotide.奥曲肽成功治疗转移性胰高血糖素瘤所致犬坏死性游走性红斑(浅表坏死性皮炎)
Vet Dermatol. 2010 Oct;21(5):510-6. doi: 10.1111/j.1365-3164.2009.00876.x. Epub 2010 May 24.
6
[Necrolytic migratory erythema].[坏死性游走性红斑]
Rev Med Liege. 1998 Dec;53(12):778-83.
7
Rapid improvement of glucagonoma-related necrolytic migratory erythema with octreotide.奥曲肽使胰高血糖素瘤相关的坏死性游走性红斑迅速改善。
Clin J Gastroenterol. 2014 Jun;7(3):255-9. doi: 10.1007/s12328-014-0471-9. Epub 2014 Apr 9.
8
A persistent periorificial eruption. Necrolytic migratory erythema (NME) (glucagonoma).持续性口周皮疹。坏死松解性游走性红斑(NME)(胰高血糖素瘤)。
Arch Dermatol. 1997 Jul;133(7):909, 912. doi: 10.1001/archderm.1997.03890430129019.
9
Necrolytic migratory erythema associated with hyperglucagonemia and neuroendocrine hepatic tumors.与高胰高血糖素血症和神经内分泌性肝肿瘤相关的坏死溶解性游走性红斑
Acta Dermatovenerol Alp Pannonica Adriat. 2005 Dec;14(4):161-4, 166.
10
Glucagonoma syndrome and necrolytic migratory erythema.胰高血糖素瘤综合征与坏死松解性游走性红斑。
Int J Dermatol. 2010 Jan;49(1):24-9. doi: 10.1111/j.1365-4632.2009.04220.x.

引用本文的文献

1
Necrolytic migratory erythema caused by pancreatic hyperglycemia with emphasis on therapeutic and prognosis: A case report.胰腺高血糖所致坏死性游走性红斑及其治疗与预后:一例报告
World J Clin Cases. 2024 Aug 16;12(23):5404-5409. doi: 10.12998/wjcc.v12.i23.5404.
2
A novel likely pathogenetic variant p.(Cys235Arg) of the MEN1 gene in multiple endocrine neoplasia type 1 with multifocal glucagonomas.一种 MEN1 基因的新型可能致病变异 p.(Cys235Arg) 与多灶性胰高血糖素瘤相关的 1 型多发性内分泌肿瘤。
J Endocrinol Invest. 2024 Jul;47(7):1815-1825. doi: 10.1007/s40618-023-02287-x. Epub 2024 Jan 31.
3
How Many Times Can One Go Back to the Drawing Board before the Accurate Diagnosis and Surgical Treatment of Glucagonoma?
在对胰高血糖素瘤进行准确诊断和手术治疗之前,一个人可以回到绘图板(重新开始)多少次?
Diagnostics (Basel). 2022 Jan 16;12(1):216. doi: 10.3390/diagnostics12010216.
4
Glucagonoma syndrome: a case report with focus on skin disorders.胰高血糖素瘤综合征:以皮肤病变为重点的 1 例病例报告。
Onco Targets Ther. 2014 Aug 14;7:1449-53. doi: 10.2147/OTT.S66285. eCollection 2014.
5
Necrolytic migratory erythema as the first manifestation of pancreatic neuroendocrine tumor.坏死性游走性红斑作为胰腺神经内分泌肿瘤的首发表现
World J Surg Oncol. 2014 Jul 17;12:220. doi: 10.1186/1477-7819-12-220.